Physician profile
David M Spiro
NPI 1932343324
$12,881.53
in general payments reported to CMS, 2019-2025
14 companies · $6,324 in 2025
The $6,324 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $427 · 2021: $440 · 2022: $1,447 · 2023: $1,249 · 2024: $1,129 · 2025: $6,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,758 · Food and Beverage: $2,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,757.50 |
| Food and Beverage | $2,944.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,410.26 | 2020-2025 | Mako, N/A, Spinemap |
| Mis Technologies, LLC | $1,089.60 | 2019 | |
| Integrity Implants INC. | $757.30 | 2019 | |
| Orthofix Medical, INC. | $456.09 | 2021-2024 | Spinal-Stim, Spinal-Stim |
| Cerapedics INC. | $350.29 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $164.30 | 2023 | |
| Depuy Synthes Sales INC. | $160.01 | 2019-2020 | |
| Ossdsign USA Incorporated | $154.64 | 2024 | |
| Globus Medical, INC. | $114.81 | 2020 | |
| Integrity Implants INC. Dba Accelus | $77.98 | 2024 | |
| Zimmer Biomet Holdings, INC. | $66.73 | 2020-2021 | |
| Zimvie INC. | $33.72 | 2023 | |
| Azurity Pharmaceuticals, INC. | $24.93 | 2023 | Gliadel |
| Livanova USA, INC. | $20.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.